1. Network Simulations Reveal Molecular Signatures of Vulnerability to Age-Dependent Stress and Tau Accumulation
   Timothy E. Hoffman et al, 2020, Frontiers in Molecular Biosciences CrossRef
2. 2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer’s diseases: In vitro and in silico studies
   Muhammad Athar Abbasi et al, 2018, Computational Biology and Chemistry CrossRef
3. Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease
   Daniela Volpato et al, 2018, Molecules CrossRef
4. An Overview of Several Inhibitors for Alzheimer’s Disease: Characterization and Failure
   Subramanian Boopathi et al, 2021, International Journal of Molecular Sciences CrossRef
5. Biophysical Psychiatry—How Computational Neuroscience Can Help to Understand the Complex Mechanisms of Mental Disorders
   Tuomo Mäki-Marttunen et al, 2019, Frontiers in Psychiatry CrossRef
6. Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease
   Alok Joshi et al, 2020, Neuropharmacology CrossRef
7. Increased oscillatory power in a computational model of the olfactory bulb due to synaptic degeneration
   J. Kendall Berry et al, 2021, Physical Review E CrossRef
8. Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
   E. Josephine Boder et al, 2021, Bioengineering CrossRef
9. Nanomedicine Against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
   null Pederzoli et al, 2019, Pharmaceutics CrossRef